Scafesia Tablet 1 mg (Finasteride)

Adult dose

Typically, 1 mg of finasteride is taken orally once daily, and it can be taken regardless of meals. Generally, treatment effects can be observed after more than 3 months of continuous use, and continuous use is recommended to maintain the treatment effect. The treatment period and effectiveness should be continuously evaluated. If treatment is discontinued, the effects will disappear within 12 months.

This medication should not be used by children or women. In particular, pregnant women or those who may become pregnant should avoid touching broken pieces of this medication, as its ingredients can be absorbed through the skin and pose a risk to the fetus. While taking this medication, depression or mood changes may occur, so if such symptoms arise, it is important to consult a healthcare professional immediately. Pregnant women should not take this medication, as taking it during pregnancy may cause abnormalities in the external genitalia of male fetuses, so caution is necessary. Patients who are allergic to this medication or its components should avoid taking it, and patients already taking other 5α-reductase inhibitors should not use this medication concurrently. Patients with lactose intolerance or allergies to soybean oil, soy, or peanuts should exercise caution when taking this medication. Patients with impaired liver function or metabolic disorders such as hyperlipidemia and diabetic dyslipidemia should also use this medication with caution. This medication may cause adverse reactions related to sexual function, including decreased libido, erectile dysfunction, and ejaculatory disorders. If such symptoms occur, consultation with healthcare professionals is required. Long-term use may report cases of breast tenderness or enlargement, as well as the potential occurrence of breast cancer, so any changes should be reported to a physician immediately. This medication may influence the risk of prostate cancer, so men over 55 should regularly monitor their PSA levels and be closely observed. As this medication may affect blood lipid levels, patients with metabolic disorders should monitor their condition through blood tests. No clinically significant interactions with other medications have been reported; however, many cases exist where it has been used without adverse reactions when combined with other medications. This medication is not administered to women, nor should it be taken by nursing mothers. In case of overdose, there are no special detoxification methods, but serious adverse reactions have not been reported in clinical trials even at high doses. This medication should be kept out of reach of children and should not be transferred to other containers. This medication does not significantly increase the risk of carcinogenicity with long-term use; however, caution is required, as certain cell proliferation has been observed in some animal studies. During clinical tests, this medication may cause PSA levels to appear low, so this should be considered when interpreting test results.

Serious side effects

Hives, angioedema (including swelling of the lips, tongue, throat, and face), rash (with severe rash possible along with fever), depression, suicidal thoughts, persistent decreased libido after discontinuation, persistent sexual dysfunction after discontinuation, male breast cancer

Mild side effects

• Decreased libido
• erectile dysfunction
• ejaculatory disorders
• breast tenderness and enlargement
• testicular pain
• hemotospermia
• orgasmic disturbances
• anxiety
• muscle pain
• myasthenia

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain the storage temperature between 15 to 30 degrees Celsius. Proper storage will help maintain the effectiveness and safety of the medication.

Appearance

Brownish-yellow, biconvex, octagonal film-coated tablet

Package unit

30 tablets (10 tablets/PTP*3)